APOA1 Antikörper (N-Term)
Kurzübersicht für APOA1 Antikörper (N-Term) (ABIN499311)
Target
Alle APOA1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- This antibody reacts to ApoA1.
-
Aufreinigung
- Affinity chromatography purified via peptide column
-
Immunogen
- ApoA1 antibody was raised against a 17 amino acid peptide from near the amino terminus of human ApoA1.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
ELISA. Western Blot: ApoA1 antibody can be used for detection of ApoA1 at 1 - 2 μg/mL. Immunofluorescence.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- PBS containing 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C.
-
-
- APOA1 (Apolipoprotein A-I (APOA1))
-
Andere Bezeichnung
- Apolipoprotein A I (APO AI)
-
Hintergrund
- Apolipoprotein A1 (ApoA1) is the major protein component of high density lipoprotein (HDL) in plasma. ApoA1 is synthesized in the liver and small intestine and promotes cholesterol efflux from tissues to the liver for excretion. It is a cofactor for lecithin cholesterolacyltransferase (LCAT), the enzyme responsible for the formation of most plasma cholesteryl esters. Defects in ApoA1 are associated with HDL deficiency, Tangier disease, and systemic non-neuropathic amyloidosis.Synonyms: APOA1, Apo-AI, ApoA-I, ApoAI
-
Gen-ID
- 335
-
UniProt
- P02647
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Lipid Metabolism
Target
-